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EDITORIAL
Respiratory  viral  coinfection  and clinical  disease  severity,
Coinfecc¸ão  viral  respiratória  e  gravidade  da  doenc¸a  clínica
Dat Tran
MD.  MSc.  Division  of  Infectious  Diseases,  Department  of  Pediatrics,  The  Hospital  for  Sick  Children,  University  of  Toronto,
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tEven  though  the  pandemic  caused  by  Inﬂuenza
A(H1N1)pdm09  (pH1N1)  infection  has  been  extensively
investigated, there  are  few  studies  that  have  examined  the
impact of  viral  coinfection  on  disease  severity,  and  they
have yielded  conﬂicting  results.  In  this  issue  of  the  Jornal
de Pediatria,  Scotta  et  al.1 report  on  a  retrospective  study
of 120  Brazilian  children  hospitalized  with  pH1N1  infection,
which found  respiratory  viral  coinfection  to  be  a  risk  factor
for respiratory  failure.  Consistent  with  this  ﬁnding,  Torres
et al.  observed  that  viral  coinfection  with  respiratory  syn-
cytial virus  (RSV)  was  associated  with  increased  mortality
in a  multivariable  analysis  of  142  children  admitted  for
intensive care  during  the  ﬁrst  pandemic  wave  in  Argentina.2
In  contrast,  viral  coinfection  was  infrequent  and  had  little
impact on  morbidity  and  mortality  in  a  sample  consisting
mostly of  adult  patients  (79.3%)  admitted  to  an  intensive
care unit  (ICU)  in  Australia.3 In  a  large  study  of  children
and adults  conducted  in  North  West  England,  coinfection
with RSV  or  adenovirus  was  associated  with  increased
risk of  admission  to  the  general  ward,  while  inﬂuenza  B
increased risk  of  admission  to  ICU;  however,  in  multivariable
logistic regression  models,  these  increases  in  risk  were  not
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http://dx.doi.org/10.1016/j.jped.2013.06.002tatistically  signiﬁcant.4 In  the  same  study,  coinfection  with
easonal inﬂuenza  A  and  inﬂuenza  B  viruses  was  associated
ith a  signiﬁcant  increase  in  risk  of  ICU  admission  or  death.
hedin et  al.  observed  no  correlation  between  detection
f additional  viruses  and  disease  severity  in  Swedish
hildren hospitalized  with  pH1N1  infection.5 Similarly,
tudies with  limited  sample  sizes  in  Spain6 and  Brazil7
ound  no  association  between  respiratory  viral  coinfection
nd severity  of  pH1N1  infection.  Meanwhile,  in  a  study
ample that  included  96  (42.0%)  children,  Esper  et  al.  found
hat rhinovirus  coinfection  had  little  impact  on  severity  of
nﬂuenza disease;  in  fact,  such  patients  had  a  lower  median
linical severity  score,  while  the  opposite  was  observed  for
on-rhinovirus coinfection.8
Similar  to  studies  of  pH1N1  infection,  reports  focusing
n the  relative  importance  of  mixed  viral  respiratory  infec-
ions generally  have  resulted  in  equally  divergent  ﬁndings.
ome studies  documented  increased  severity9--11 of  respira-
ory illness  in  children  infected  with  two  or  more  viruses
ompared to  those  with  single  virus  infections,  while  some
bserved the  opposite.12--14 Other  studies  found  no  associ-
tion of  respiratory  coinfections  with  illness  severity.15--17
hese  discrepant  ﬁndings  may  be  explained  by  several  fac-
ors. They  include  differences  in  the  population  studied
variation in  age  ranges,  breadth  of  illness  severity,  and  pro-
ortions of  subjects  with  comorbid  conditions),  geographical
nd seasonal  differences  regarding  circulating  respiratory
iruses, method  of  viral  detection  (traditional  methods,  such
s culture  and  direct  immunoﬂuorescence,  versus  molecular
ssays), and  composition  and  performance  characteristics  of
   er Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
4t
d
S
v
d
u
t
I
p
t
t
v
o
e
l
v
v
t
c
t
n
i
i
p
l
w
c
e
t
o
r
s
n
t
t
i
t
l
v
f
r
m
w
a
s
f
v
e
e
f
i
p
c
i
s
c
b
p
b
m
c
i
u
e
i
d
p
o
v
t
m
p
C
T
R
1
1
122  
he  molecular  respiratory  panels.  The  mechanisms  driving
isease virulence  in  coinfections  are  not  clearly  understood.
ome authors  have  proposed  three  major  groups  of  virus-
irus interactions  to  explain  potential  mechanistic  models  of
isease: (1)  direct  interactions  of  viral  genes  or  gene  prod-
cts, (2)  indirect  interactions  resulting  from  alterations  in
he host  environment,  and  (3)  immunological  interactions.18
n  this  context,  it  would  not  be  surprising  for  different
athogenic mechanisms  to  be  triggered  by  different  viruses
hat mutually  potentiate  or  mitigate  each  other’s  effects;
hus, certain  pairings  of  viruses  may  be  more  clinically  rele-
ant than  others.  Furthermore,  the  simultaneous  detection
f multiple  viruses  does  not  necessarily  implicate  pathogenic
ffect at  the  time  of  detection,  especially  when  molecu-
ar methods  are  used.  In  some  instances,  detection  of  two
iruses may  represent  an  acute  infection  in  the  presence  of
iral persistence  from  a  recent  infection.19
The  potential  confounding  inﬂuence  of  concurrent  bac-
erial infections  is  another  important  factor  that  may  have
ontributed to  the  conﬂicting  results  in  studies  examining
he role  of  respiratory  viral  coinfection  in  the  determi-
ation of  disease  severity  due  to  respiratory  infections,
ncluding inﬂuenza.  Inﬂuenza  and  other  respiratory  viral
nfections are  known  to  predispose  to  secondary  bacterial
ulmonary infection.20 Bacterial  coinfection  complicates  at
east 2.5%  of  inﬂuenza  cases  in  older  individuals  and  those
ith predisposing  conditions.20 In  a  series  of  838  criti-
ally ill  children  with  pH1N1  infection,  22%  had  clinical
vidence of  bacterial  coinfection  along  with  positive  bac-
erial cultures.21 Thus,  failure  to  account  for  the  inﬂuence
f bacterial  coinfection  may  bias  results.  For  example,  a
ecent study  by  Chorazy  et  al.13 of  346  archived  respiratory
pecimens from  children  treated  for  acute  respiratory  ill-
ess at  the  University  of  Iowa  Hospitals  and  Clinics  found
hat children  with  viral  coinfections  were  less  likely  than
hose with  single  virus  infections  to  require  intensive  care
n unadjusted  analysis.13 However,  the  authors  observed
hat children  with  virus-bacteria  coinfections  were  more
ikely to  require  ICU  admission  than  those  with  single
irus infections,  even  after  controlling  for  potential  con-
ounders; they  also  found  that  virus-bacteria  coinfections
epresented a  greater  proportion  of  virus-positive  speci-
ens than  virus-virus-bacteria  coinfections.  Once  children
ith virus-bacteria  coinfections  were  excluded  from  the
nalysis, the  observed  odds  ratio  moved  toward  the  null,
uggesting that  the  observed  association  of  virus-virus  coin-
ection with  better  outcome  can  be  partly  explained  by
irus-bacteria coinfection.  Besides  the  study  by  Chorazy
t al.,13 a  minority  of  the  studies  cited  in  the  present
ditorial either  considered  or  adjusted  for  bacterial  coin-
ection, or  a  proxy  thereof,  as  a  potential  confounder
n the  analysis.5,11,12,17 Even  when  such  adjustments  are
erformed, residual  confounding  by  undetected  bacterial
oinfections may  remain,  as  exempliﬁed  by  Scotta  et  al.1
n  this  issue  of  the  Jornal  de  Pediatria.  The  authors  had
tipulated bacterial  co-detection  (deﬁned  as  a  positive
ulture for  a  possible  pathogen  in  respiratory  secretions,
lood, or  other  sterile  specimens)  as  one  of  the  inde-
endent variables  to  be  examined,  but  presented  no
acterial co-detection  data,  presumably  due  to  the  lack  of
icrobiologically-conﬁrmed bacterial  infection  in  the  study
ohort.
1Tran  D
The increasing  use  of  molecular  respiratory  viral  panels
n clinical  settings  underscores  the  importance  of  a  fuller
nderstanding of  the  impact  of  viral  coinfection  on  dis-
ase severity.  Future  prospective  longitudinal  studies  that
nclude serial  respiratory  tract  sampling,  not  only  for  virus
etection but  also  for  mechanistic  experiments,  will  be
aramount to  the  understanding  of  the  clinical  signiﬁcance
f polymicrobial  acute  respiratory  infections,  as  well  as
iral pathogenesis.  Implementation  of  multiplex  quantita-
ive polymerase  chain  reaction  assays  into  the  study  design
ay also  be  a  worthwhile  goal,  as  is  the  precise  and  com-
rehensive identiﬁcation  of  bacterial  coinfection.
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